51644-83-8

Usage

Uses

Used in Pharmaceutical Research:
Z-D-GLU(OTBU)-OH is used as a chiral building block for the synthesis of complex molecules, which are essential in the development of new pharmaceuticals and biologically active compounds. Its ability to create enantiomerically pure compounds contributes to the advancement of drug discovery and design.
Used in Organic Synthesis:
In the field of organic synthesis, Z-D-GLU(OTBU)-OH is employed as a key intermediate for the preparation of various organic compounds. Its versatility and reactivity make it a preferred choice for chemists working on the synthesis of target molecules with specific stereochemistry.
Used in Drug Development:
Z-D-GLU(OTBU)-OH is utilized in drug development as a precursor for the synthesis of pharmaceuticals with potential therapeutic applications. Its role in creating enantiomerically pure compounds ensures the desired biological activity and minimizes potential side effects associated with racemic mixtures.
Used in the Production of Biologically Active Compounds:
Z-D-GLU(OTBU)-OH is used as a starting material for the synthesis of biologically active compounds, which have potential applications in various industries, such as agriculture, pharmaceuticals, and cosmetics. Its ability to form complex molecules with specific biological activities makes it a valuable tool for the development of novel bioactive agents.

InChI:InChI=1/C17H23NO6/c1-17(2,3)24-14(19)10-9-13(15(20)21)18-16(22)23-11-12-7-5-4-6-8-12/h4-8,13H,9-11H2,1-3H3,(H,18,22)(H,20,21)/t13-/m1/s1

Upstream product

• 501-53-1 benzyl chloroformate 
• 45125-00-6 (R)-2-amino-5-(tert-butoxy)-5-oxopentanoic acid 

Downstream Products

• 140837-98-5 (R)-2-(((benzyloxy)carbonyl)(methyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid 
• 35793-61-4 (S)-2-((R)-2-Benzyloxycarbonylamino-4-tert-butoxycarbonyl-butyrylamino)-pentanedioic acid 5-tert-butyl ester 1-methyl ester 
• 63648-73-7 N-benzyloxycarbonyl-D-glutamic acid 
• 512783-86-7 N-[(benzyloxy)carbonyl]-D-glutamic acid γ-tert-butyl ester α-[3-(trifluoromethyl)benzyl]amide 
• 77277-62-4 N-(benzyloxycarbonyl)-L-valyl-D-isoglutamine t-butyl ester 
• 151301-90-5 1-dimethylethyl 5-[[4-(4-cyanophenyl)butyl]amino]-5-oxo-4(R)-[[(phenylmethoxy)carbonyl]amino]pentanoate 
• 106930-52-3 tert-butyl (4R)-4-{[(benzyloxy)carbonyl]amino}-5-hydroxypentanoate 
• 1025728-85-1 C₂₉H₃₅N₃O₇ 
• 1025728-78-2 C₃₃H₄₅N₃O₇Si 
• 1273534-82-9 C₃₈H₅₅N₅O₉ 
• 174488-24-5 tert-butyl (4R)-4-{N-{N-{4-[N-((6RS)-2-methyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-α-tert-butyl-L-γ-glutamyl}amino}-4-(5-tetrazolyl)butyrate 
• 174488-22-3 tert-butyl (4R)-4-{N-[N-(benzyloxycarbonyl)-α-tert-butyl-L-γ-glutamyl]amino}-4-(5-tetrazolyl)butyrate 
• 174488-20-1 tert-butyl (4R)-4-(benzyloxycarbonylamino)-4-(5-tetrazolyl)butyrate 

Relevant academic research and scientific papers

IMMUNOSTIMULATING AGENT

The present invention aims to provide an immunostimulating agent superior in an immunostimulatory effect, particularly a compound useful as a vaccine adjuvant, a pharmaceutical composition containing the compound, a vaccine containing the compound and an

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.